EntryPoint Capital’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-323,968
Closed -$496K 1615
2023
Q4
$496K Buy
+323,968
New +$496K 0.48% 6